Enalapril vs Ipilimumab

Enalapril vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Enalapril and Ipilimumab.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Enalapril — 11 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Enalapril — Small molecule; Ipilimumab — Antibody.